Functional studies of various Plasmodium genes and their gene products are essential prerequisites for the discovery of effective vaccine and antimalarial drug targets, but the functions of many genes, especially those important genes related to the pathogenicity of Plasmodium, have not been elucidated, thus affecting malaria control efforts. The Plasmodium gene transfection technique allows the function of genes to be studied in vivo by observing phenotypic changes after altering the genes. This technology has also led to new technological changes in the regulation of Plasmodium gene expression, drug resistance studies, cell biology, and vaccine research. Of the four species of Plasmodium infecting humans, Plasmodium falciparum is the most pathogenic, and its research has received much attention.
Ace Therapeutics specializes in parasitology and has established a parasite genetic engineering technology platform designed to provide genetic engineering services for a variety of parasitic diseases to clients worldwide. We are able to provide transfection services for Plasmodium falciparum to our global clients, laying the foundation for in-depth elucidation of mechanistic studies.
We have established a gene transfection system for Plasmodium, the causative agent of malaria, primarily utilizing the electroporation transformation method. Our Malaria parasite transfection service is currently undergoing further optimization and improvement. If you would like to learn more, please feel free to consult us for further details.
Electroporation transformation methods
Types of Plasmodium gene transfection
Application of Plasmodium gene transfection
Delivery content: experiment report and products of Plasmodium gene transfection
Test fee: please get it through online inquiry .
Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.